Literature DB >> 34216730

Paraoxonase 2 deficiency in mice alters motor behavior and causes region-specific transcript changes in the brain.

Jacqueline M Garrick1, Toby B Cole2, Theo K Bammler3, James W MacDonald3, Judit Marsillach3, Clement E Furlong4, Lucio G Costa5.   

Abstract

Paraoxonase 2 (PON2) is an intracellular antioxidant enzyme shown to play an important role in mitigating oxidative stress in the brain. Oxidative stress is a common mechanism of toxicity for neurotoxicants and is increasingly implicated in the etiology of multiple neurological diseases. While PON2 deficiency increases oxidative stress in the brain in-vitro, little is known about its effects on behavior in-vivo and what global transcript changes occur from PON2 deficiency. We sought to characterize the effects of PON2 deficiency on behavior in mice, with an emphasis on locomotion, and evaluate transcriptional changes with RNA-Seq. Behavioral endpoints included home-cage behavior (Noldus PhenoTyper), motor coordination (Rotarod) and various gait metrics (Noldus CatWalk). Home-cage behavior analysis showed PON2 deficient mice had increased activity at night compared to wildtype controls and spent more time in the center of the cage, displaying a possible anxiolytic phenotype. PON2 deficient mice had significantly shorter latency to fall when tested on the rotarod, suggesting impaired motor coordination. Minimal gait alterations were observed, with decreased girdle support posture noted as the only significant change in gait with PON2 deficiency. Beyond one home-cage metric, no significant sex-based behavioral differences were found in this study. Finally, A subset of samples were utilized for RNA-Seq analysis, looking at three discrete brain regions: cerebral cortex, striatum, and cerebellum. Highly regional- and sex-specific changes in RNA expression were found when comparing PON2 deficient and wildtype mice, suggesting PON2 may play distinct regional roles in the brain in a sex-specific manner. Taken together, these findings demonstrates that PON2 deficiency significantly alters the brain on both a biochemical and phenotypic level, with a specific impact on motor function. These data have implications for future gene-environment toxicological studies and warrants further investigation of the role of PON2 in the brain.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Behavior; Brain; Mouse; PON2; Paraoxonase 2; RNA-Seq

Mesh:

Substances:

Year:  2021        PMID: 34216730      PMCID: PMC8440460          DOI: 10.1016/j.ntt.2021.107010

Source DB:  PubMed          Journal:  Neurotoxicol Teratol        ISSN: 0892-0362            Impact factor:   4.071


  59 in total

1.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

2.  Analysis and correction of crosstalk effects in pathway analysis.

Authors:  Michele Donato; Zhonghui Xu; Alin Tomoiaga; James G Granneman; Robert G Mackenzie; Riyue Bao; Nandor Gabor Than; Peter H Westfall; Roberto Romero; Sorin Draghici
Journal:  Genome Res       Date:  2013-08-09       Impact factor: 9.043

3.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

4.  Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stress-induced caspase activation.

Authors:  Sven Horke; Ines Witte; Petra Wilgenbus; Maximilian Krüger; Dennis Strand; Ulrich Förstermann
Journal:  Circulation       Date:  2007-04-02       Impact factor: 29.690

5.  Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein.

Authors:  C J Ng; D J Wadleigh; A Gangopadhyay; S Hama; V R Grijalva; M Navab; A M Fogelman; S T Reddy
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

Review 6.  Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders.

Authors:  Mohammad Fahad Ullah; Aamir Ahmad; Showket Hussain Bhat; Faisel M Abu-Duhier; George E Barreto; Ghulam Md Ashraf
Journal:  Neurosci Biobehav Rev       Date:  2019-04-05       Impact factor: 8.989

Review 7.  Sex differences in stress-related psychiatric disorders: neurobiological perspectives.

Authors:  Debra A Bangasser; Rita J Valentino
Journal:  Front Neuroendocrinol       Date:  2014-04-12       Impact factor: 8.606

8.  Dibutyl Phthalate (DBP)-Induced Apoptosis and Neurotoxicity are Mediated via the Aryl Hydrocarbon Receptor (AhR) but not by Estrogen Receptor Alpha (ERα), Estrogen Receptor Beta (ERβ), or Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Mouse Cortical Neurons.

Authors:  Anna K Wójtowicz; Konrad A Szychowski; Agnieszka Wnuk; Małgorzata Kajta
Journal:  Neurotox Res       Date:  2016-08-31       Impact factor: 3.911

9.  Location- and sex-specific differences in weight and motor coordination in two commonly used mouse strains.

Authors:  Attila D Kovács; David A Pearce
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

Review 10.  Reactive Oxygen Species: A Key Constituent in Cancer Survival.

Authors:  Seema Kumari; Anil Kumar Badana; Murali Mohan G; Shailender G; RamaRao Malla
Journal:  Biomark Insights       Date:  2018-02-06
View more
  2 in total

1.  Expression of PON2 isoforms varies among brain regions in male and female African green monkeys.

Authors:  Sumit Jamwal; Jennifer K Blackburn; John D Elsworth
Journal:  Free Radic Biol Med       Date:  2021-12-07       Impact factor: 7.376

2.  Examining the role of paraoxonase 2 in the dopaminergic system of the mouse brain.

Authors:  Jacqueline M Garrick; Khoi Dao; Lucio G Costa; Judit Marsillach; Clement E Furlong
Journal:  BMC Neurosci       Date:  2022-09-02       Impact factor: 3.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.